Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Experimental cell therapy tested for Tough-to-Treat lung cancer
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called TC-D101 CAR-T for people with advanced small cell lung cancer that has come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how well the body tolerates the treatmen…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New immune cell therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for people with advanced solid tumors that have a specific protein called ALPP. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target the cancer, and then infusing them b…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC